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Abstract
Background
National	Health	Service	(NHS)	111,	a	medical	helpline	for	urgent	care	used	within	the	England	and	Scotland,	receives	significant	numbers	of	patient	calls	yearly	for	a	range	of	clinical	conditions.	Some	are	considered
high	acuity	and	mainly	directed	to	urgent	and	emergency	care.	Low	acuity	conditions	are	also	directed	to	these	costly,	overburdened	services.	Community	pharmacy	is	a	recognised	setting	for	effective	low	acuity	condition
management	and	could	offer	an	alternative.
Objective
To	design	and	evaluate	a	new	NHS111	pathway	re-directing	patients	with	low	acuity	conditions	to	community	pharmacy.
Methods
Two	consensus	development	stakeholder	workshops	were	undertaken.	A	“low	acuity”	condition	was	defined	as	one	that	can	be	clinically	assessed	by	a	community	pharmacist	and	requires	a	treatment	and/or	advice
available	within	a	community	pharmacy.	Retrospective	NHS111	patient	data	(February–August	2016)	from	the	North	East	of	England	and	access	to	the	NHS	Pathways	clinical	decision	support	software	were	available	to
stakeholders.	The	NHS111	data	demonstrated	the	volume	of	patient	calls	for	these	conditions	that	could	have	been	redirected	to	community	pharmacy.
Results
Stakeholders	reached	consensus	that	64	low	acuity	conditions	could	be	safely	redirected	to	community	pharmacy	via	NHS111.	This	represented	approximately	35,000	patients	(11.5%	of	total)	being	shifted	away	from
the	 higher	 cost	 settings	 in	 the	North	 East	 region	 alone	 during	 February–August	 2016.	 The	 stakeholder	 group	 discussions	 provided	 rationale	 behind	 their	 classifications	 of	 conditions	 to	 ensure	 patient	 safety,	 the	 care
experience	and	added	value.
Conclusions
1	Introduction
Emergency	departments	(ED)	in	England	can	receive	up	to	22.4	million	attendances	in	one	year	(2014–15).1	General	practice	(GP)	is	similarly	facing	unsustainable	pressures	with	372	million	GP	consultations	conducted	over
the	same	period.2	A	recent	report	claimed	that	5%	of	ED	consultations	and	13%	of	GP	consultations	are	for	low	acuity	conditions.3	These	are	defined	as	‘common	or	self-limiting	or	uncomplicated	conditions	which	may	be	diagnosed	and
managed	without	medical	(i.e.	doctor)	intervention’.4
This	issue	is	shared	in	similar	economies	worldwide.	A	recent	study	in	Ontario,	Canada	reported	that	12.3%	ED	visits	between	April	2008–March	2009	were	for	low	acuity	conditions	made	by	young	adults	and	representing	the
most	deprived	population.5	Another	study	in	Norway	reported	that	28%	of	out-of-hours	consultations	in	November	and	December	2008	were	dedicated	to	conditions	classified	as	minor	ailments.6
The	UK	health	department	has	clearly	advocated	for	low	acuity	conditions	to	be	managed	in	community	pharmacy,	thus	freeing	up	physicians'	time	and	costly	resources	in	ED	departments.3,7	In	response	to	this	political	drive,
community	pharmacy	minor	ailment	schemes	were	developed	to	provide	patients	with	an	alternative	setting	to	receive	timely	treatment	and	advice.3	The	Clinical	Services	Review	identified	barriers	for	community	pharmacies	in	setting
up	such	schemes,	including	the	lack	of	digital	interoperability	that	would	facilitate	information	transfer	between	community	pharmacy	and	the	wider	NHS.8
NHS	111	was	officially	launched	in	February	2014	as	the	telephone	triage	service	for	urgent	and	emergency	care	(UEC)	in	England.	When	a	patient	calls	NHS	111,	non-clinical	staff	who	are	supported	by	nurses,	paramedics
and	GPs	ask	the	patient	a	series	of	questions	to	help	guide	the	telephonic	triage	process.9	This	questioning	process	is	guided	in	part	by	a	computerised	software,	called	NHS	Pathways,	which	has	been	suggested	to	be	risk	averse	and
could	be	improved.9
The	GP	Five	Year	Forward	View10	specifically	recommended	the	more	effective	use	of	community	pharmacy	to	manage	patient	demand	and	 improve	GP	capacity.	The	document	referred	to	coupling	the	reformed	NHS	111
service	with	pharmacy	minor	ailment	schemes	to	improve	patient	flows.10	However,	it	is	currently	unclear	which	specific	patients	should	be	redirected	to	community	pharmacy.	There	has	also	been	no	extensive	work	undertaken	within
NHS	111	to	establish	community	pharmacy	as	a	safe	and	appropriate	alternative	pathway	of	care	for	low	acuity	patients	away	from	overburdened	and	costly	UEC.
The	aim	of	the	study	was	to	classify	low	acuity	conditions	that	could	be	managed	within	community	pharmacy	and	design	and	evaluate	a	new	NHS	111	pathway	to	redirect	patients	with	these	conditions	to	community	pharmacy
away	from	UEC.
2	Methods
This	study	was	carried	out	in	the	North	East	of	England,	using	NHS	111	data	from	the	NHS	111	Provider	using	the	commissioner	dashboard	and	was	financially	supported	by	NHS	England.	The	study	received	ethical	approval
from	the	Research	Ethics	Committee	of	the	Durham	University	School	of	Medicine,	Pharmacy	and	Health	(ref	no.	ESC2/2016/PP03)	to	conduct	two	consensus	development	workshops.
2.1	Participants
Fig.	1	provides	a	diagrammatic	representation	of	key	stakeholders	involved	in	the	management	and	operation	of	NHS	111	services	at	a	regional	level	and	their	subsequent	impact	on	any	patient	callers	to	the	medical	helpline.
The	resulting	definitive	list	of	low	acuity	conditions	that	could	be	directed	to	community	pharmacy	via	NHS111	could	result	in	a	shift	of	workload	from	urgent	and	emergency	care	settings.	Future	work	needs	to	evaluate
the	cost,	clinical	outcomes,	patient	satisfaction	of	a	community	pharmacy	referral	service	that	has	the	potential	to	improve	integration	of	community	pharmacy	in	the	wider	NHS.
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Three	members	of	the	research	team	[AC,	MM,	and	AY]	work	within	at	least	one	of	these	stakeholder	groups	and	were	therefore	able	to	identify	the	individuals	required	to	include	in	the	consensus	activities	to	determine	a	new
NHS	111	Pathway.	Purposive	sampling	was	used	to	invite	this	wide	range	of	individuals	with	different	roles	in	the	NHS	111	system	as	per	Fig.	1,	some	of	whom	had	clinical	and/or	operational	expertise	(S1	Appendix	 illustrates	 the
knowledge	and	experience	of	the	stakeholders	invited).	A	total	of	15	stakeholders	were	invited	to	attend	two	workshops.	Ideally,	a	group	size	of	between	6	and	12	participants	was	aimed	for,	as	smaller	numbers	could	possibly	diminish
reliability	and	 larger	numbers	decrease	capability	 to	 coordinate	activities	and	consensus.11,12	Consensus	methodologies	 such	as	an	 interacting	group	decision-making	process	and	 the	nominal	group	process	are	 valuable	where	a
specific	problem	exists	that	requires	a	specific	answer.	The	acknowledged	debate	and	interactivity	are	reported	to	be	more	time	efficient	to	answer	specific	problems	than	focus	groups,	which	have	the	aim	to	reach	theoretical	(or	data)
saturation.11	Individuals	for	the	first	workshop	were	invited	by	email	in	September	2016,	with	the	workshop	conducted	in	October	2016.	After	the	first	workshop,	it	was	decided	that	the	addition	of	an	NHS	111	pharmacist	and	an	NHS
111	clinical	advisor	to	the	group	would	be	beneficial.	A	member	of	the	project	team	[AC],	who	also	works	within	the	NHS	111	system,	approached	individuals	working	in	these	roles	at	NHS	111	in	January	2017	and	invited	them	to
attend	the	second	workshop,	which	was	conducted	in	February	2017.
Eleven	and	fourteen	stakeholders	attended	workshops	1	and	2,	respectively.	Each	workshop	included	representatives	from	commissioners,	out	of	hours'	services	(OOH),	Directory	of	Services	(DoS),	and	team	leaders	working
within	the	NHS	111	system	(Table	1).
Table	1	The	attendance	of	key	stakeholders	at	the	two	workshops.
Fig.	1	The	stakeholder	roles	and	influences	within	the	NHS	111	system	that	interact	at	every	patient	call.
alt-text:	Fig.	1
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At	both	workshops,	participants	were	informed	of	the	key	objectives	and	format.	Written	consent	for	the	audio	recording	of	discussions	was	obtained	prior	to	commencement	of	each	workshop.
2.2	Workshop	1:	identification	of	low	acuity	patient	conditions
The	first	workshop	was	organised	as	an	interacting	group	decision-making	process.	This	represents	the	most	traditional	and	most	widely	used	method	for	group	decision	making	in	organisational	committees.	These	follow	a
typical	format	of	an	interactive	group	meeting,	where	the	group	leader	opens	with	a	statement	of	the	problem	and	an	unstructured	group	discussion	ensues	that	generates	information	and	pooling	of	judgements	among	participants.
The	meeting	then	concludes	with	a	majority	voting	procedure	on	priorities,	or	a	consensus	decision.12	The	purpose	of	the	first	workshop	was	to	broadly	discuss	which	patient	conditions	listed	within	NHS	Pathways	were	“low	acuity”
conditions	and	could	be	potentially	re-directed	to	the	community	pharmacy.
Participants	were	presented	with	six	months	(February–August	2016)	of	retrospective	anonymised	patient	call	data,	which	were	downloaded	from	the	commissioner	dashboard;	an	interface	for	commissioning	organisations	to
access	data	about	service	usage,	demand	and	supply.13	This	equated	to	approximately	305,646	NHS	111	calls.
These	NHS	111	data	contained	information	about:
(1) The	patient's	presenting	condition	or	“Symptom	Group”	(SG	code)	e.g.,	coughs;
(2) A	“Symptom	Discriminator”	(SD	code)	which	indicated	the	level	of	care	and	skillset	considered	necessary	to	assess	and	manage	the	symptom	e.g.,	Full	primary	care	assessment	and	prescribing	capability	(S2	Appendix	shows	the	5	main	SD	codes	and	some	examples
of	sub-types);	and
(3) A	Disposition	(DX	code)	which	indicated	the	timeframe	within	which	the	patient	was	recommended	to	seek	care	(e.g.,	the	patient	is	recommended	to	speak	to	a	primary	care	professional	within	24	h)	and	the	type	of	attention	that	would	be	appropriate,	e.g.,	physical
attendance	presentation	to	a	healthcare	professional	(S3	Appendix	shows	the	timeframe	and	skillset	that	are	recommended).
To	summarise,	this	generated	a	SG/SD/DX	combination,	as	illustrated	in	Fig.	2,	which	then	guided	the	call	handler	to	recommend	a	particular	course	of	action.13
Participants	were	first	presented	with	the	114	most	highly	recorded	SD	codes	(as	evidenced	in	the	6months	NHS	111	patient	caller	data)	out	of	a	total	124	SD	codes	with	a	range	of	different	acuity	levels	(e.g.,	‘primary	care:
minor	condition’	to	‘emergency	department:	significant	burn’).	This	was	done	to	remove	the	conditions	that	warranted	exceptionally	rare	and/or	specific	level	of	care	that	would	have	been	inappropriate	to	be	managed	by	a	community
pharmacist.	The	group	was	asked	to	assess	each	SD	code	individually	(e.g.,	assessment	and	management	by	a	community	pharmacist	of	minor	conditions)	and	then,	if	they	unanimously	agreed,	the	group	went	through	the	related	list	of
more	specific	SG	codes	(e.g.,	assessment	and	management	of	‘blisters’,	this	is	the	code	that	provides	information	on	the	presenting	complaint).	A	unanimous	opinion	was	required	for	each	SG/SD	combination.	Agreed	combinations
were	entered	onto	a	live	Excel	spreadsheet	that	was	projected	onto	one	wall	of	the	meeting	room	for	the	group	to	view	and	update	accordingly.
Once	all	SG/SD	combinations	had	been	discussed,	participants	were	 then	asked	 to	consider	 the	appropriate	 timeframe	 (DX	code)	within	which	patients	should	seek	appropriate	healthcare	advice	and/or	assistance	 from	a
community	pharmacy	for	each	combination.	The	timeframe	needed	to	be	appropriate	across	all	identified	combinations.
At	the	end	of	the	workshop,	the	project	team	collated	the	findings	and	produced	a	summary	document	of	the	SG/SD/DX	combinations	that	had	been	selected	by	the	panel	as	low	acuity	conditions	that	could	potentially	be	re-
directed	to	the	community	pharmacy.
The	research	team	filtered	the	NHS	111	data	(February–August	2016)	to	identify	the	volume	of	calls	attributed	to	this	list	of	consensus	SG/SD/DX	combinations.
After	the	workshop,	this	summary	was	sent	to	participants	electronically,	and	they	were	asked	to	provide	comment	on	the	accuracy	of	the	recording	of	the	events	and	findings.
Fig.	2	A	description	of	the	different	steps	involved	in	NHS	111	Pathways	system.
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2.3	Workshop	2:	clinical	validation	of	the	low	acuity	patient	conditions
The	second	workshop	was	a	structured	process	 following	the	nominal	group	process	 (NGP).	This	 is	another	 formal	consensus	development	method	which	provides	structure	to	a	group	decision-making	process,	usually	by
adopting	a	rating	or	ranking	procedure	to	represent	extent	of	agreement	about	predefined	issues	or	questions.11	This	structure	was	adopted	where	group	members	were	required	to	reconsider	the	low	acuity	conditions	categorised	in
workshop	1.	The	elements	of	evaluation	and	clarification	afforded	by	the	NGP	provided	the	opportunity	for	more	detailed	clinical	interpretation	of	the	combination	generated	by	the	NHS	Pathways	algorithm,	e.g.	investigation	of	the
call	handler's	specific	questions,	and	patient	answers	to	trigger	the	code,	thereby	clinically	assessing	the	appropriateness	of	management	by	a	community	pharmacist.
The	overall	goal	of	the	second	workshop	was	to	clinically	validate	the	low	acuity	conditions	identified	in	the	first	workshop.
Using	the	NGP	adapted	by	Harvey	and	Holmes,11	participants	were	provided	with	an	individual	list	of	the	low	acuity	conditions	described	by	their	SG/SD/DX	combinations	as	categorised	at	workshop	1	and	asked	to	‘tick’	those
conditions	that	could	be	appropriately	referred	to	community	pharmacy.	If	participants	felt	that	they	required	more	information	on	the	NHS	Pathways	algorithm	strands	to	inform	their	decision-making,	they	were	asked	to	provide	a
‘cross’	next	to	it	(Step	1,	the	‘Silent	round’).	In	the	second	step,	participants	were	invited	to	share	their	allocations	by	using	the	‘round	robin’	technique.	This	involved	each	participant	entering	their	selection	of	low	acuity	conditions
onto	a	master	Excel	spreadsheet,	which	was	projected	onto	the	wall	at	the	front	of	the	room.	At	Step	3,	the	group	was	divided	into	two	as	these	groups	should	ideally	be	small	to	facilitate	more	in-depth	discussions	to	clarify,	discuss
and	negotiate	the	allocations	that	did	not	reach	consensus	(crosses	and/or	ticks)	in	Step	2.14	Each	group	was	homogenous	in	the	mix	of	clinical	and	non-clinical	expertise,	and	discussions	were	guided	by	the	following	two	questions:
1. Does	the	assessment	for	this	condition	fall	within	the	competence	of	a	community	pharmacist?
2. Is	the	medicinal	product	or	healthcare	advice	that	is	required	to	manage	the	condition	available	from	a	community	pharmacy?
Where	conditions	achieved	positive	answers	to	these	questions,	the	groups	then	considered	the	added	value	of	a	community	pharmacist	consultation,	e.g.	face-to-face	contact	with	a	healthcare	professional,	symptomatic	relief
with	a	pharmacist	recommended	non-prescription	product,	and	discussed	the	potential	of	any	patient	safety	issues	that	could	arise.
Groups	were	provided	with	access	to	the	NHS	Pathways	questioning	software	to	work	backwards	from	generated	SG/SD/DX	combinations.	S4	Appendix	shows	the	information	a	call	handler	obtained	from	a	patient	with	reported
rectal	bleeding	that	resulted	in	NHS	Pathways	generating	a	disposition	or	recommendation	to	see	a	GP	within	3	days	in	the	case	of	no	improvement.	NHS	111	team	members	were	able	to	explain	and	demonstrate	within	the	offline
NHS	Pathways	programme,	that	SG	codes	in	NHS	Pathways	are	initiated	based	upon	the	patient's	description	of	the	condition	rather	than	accurate	clinical	terminology	as	perceived	by	a	clinician.	As	such,	participants	were	conscious
that	 some	 clinical	 leniency	was	 required	 in	 interpreting	 the	 accuracy	 of	 the	 presenting	SG	as	 recorded	 in	 the	NHS	Pathways	 system.	 It	 became	 clear	 that	 some	 of	 the	 terms	used	within	 the	 computerised	 system	held	 differing
connotations	for	the	various	members	of	the	group.	For	example,	‘painful	eye’,	which	was	sometimes	given	an	SD	code	of	‘minor	condition’,	was	interpreted	by	the	clinicians	to	be	of	a	higher	acuity	than	could	be	understood	from	this
SD	code.	Clinicians	deemed	such	a	symptom	could	require	specific	medical	attention	for	differential	diagnosis	in	order	to	rule	out	potential	conditions	that	a	community	pharmacist	may	not	recognise	and,	in	some	cases,	may	not	be
able	to	manage,	e.g.,	acute	glaucoma.	The	discussions	and	demonstrations	with	the	computerised	software	provided	workshop	members	with	more	insight	about	how	NHS	Pathways	categorises	patient	calls	e.g.	using	information
related	to	patient	signs,	symptoms,	demographics,	etc.	This	 facilitated	the	ability	to	determine	the	appropriateness	of	managing	these	patients	within	the	community	pharmacy	or	 if	another	healthcare	professional	would	be	more
appropriate.
At	the	end	of	these	parallel	discussions	both	groups	were	asked	to	collectively	allocate	‘ticks’	and	‘crosses’	against	the	conditions	discussed	in	Step	3	to	indicate	their	suitability	to	be	managed	within	community	pharmacy.	The
lists	from	both	groups	were	compiled,	and	the	low	acuity	conditions	that	achieved	consensus	across	the	two	groups	represented	the	group	decision.13 (This	should	be	reference	15	not	13.)
At	the	end	of	the	workshop,	the	project	team	collated	the	findings	and	produced	a	summary	document	of	the	SG/SD/DX	combinations	that	had	been	selected	by	the	panel	as	low	acuity	conditions	that	could	potentially	be	re-
directed	to	the	community	pharmacy.
Again,	the	research	team	used	the	final	list	of	low	acuity	conditions	to	identify	the	volume	of	calls	attributed	to	the	consensus	SG/SD/DX	combinations.
2.4	Data	analysis
The	nominal	group	discussions	were	audio	recorded	with	permission	and	transcribed	verbatim.	Analysis	of	the	qualitative	data	was	guided	by	the	framework	analysis	approach,	which	offers	a	pragmatic	approach	to	evaluating
qualitative	data.16
The	 a	 priori	 themes	 of	 the	 framework	were	 informed	by	 the	 elements	 of	 failure	mode	 and	 effects	 analysis	 (FMEA).17	 This	 is	 a	 structured	method,	widely	 used	 in	 healthcare	 as	 a	 systematic	 approach	 of	 prospective	 risk
mitigation.	In	brief,	a	multidisciplinary	team	maps	out	a	high-risk	process	of	care	to	identify	failures	that	can	occur	(‘failure	mode’).	These	are	then	characterised	in	terms	of	effects:	probability	of	occurrence,	severity	of	effects	and
detectability.	A	risk	priority	is	calculated	for	each	failure	mode	that	then	guides	the	prioritisation	of	actions	and	recommendations	to	prevent	or	mitigate	against	it.18
To	develop	a	coding	scheme	to	analyse	the	qualitative	data,	transcripts	from	3	randomly	selected	interviews	were	each	independently	coded	by	2	evaluators	{HN	and	ZN}.	Where	other	themes	emerged	from	data	they	were
added	into	the	framework,	and	the	evaluators	came	to	consensus	on	the	final	framework.	The	two	researchers	independently	coded	the	remaining	transcripts,	compared	themes	and	came	to	consensus,	modifying	the	framework	as
needed	to	ensure	convergence	and	divergence	of	the	thematic	coding	scheme.
2.5	Notes	on	methodology	and	analysis
In	order	to	assure	trustworthiness	of	this	study	as	recommended	by	Lincoln	and	Guba,19	the	following	strategies	have	been	employed	during	data	collection	and	analysis:
1. 	Credibility	of	the	work	has	been	afforded	by:	all	findings	from	the	consensus	workshops	were	reported	back	to	participants	to	serve	as	‘member-checks’.19	Also	the	work	has	been	a	team	effort	with	input	from	representatives	of	many	of	the	representative	stakeholder
groups	involved	in	the	consensus	workshops.
2. The	level	of	detail,	which	can	be	described	as	‘thick	description,19	provided	with	regards	to	terminology,	data	in	NHS	111,	transparency	of	the	filtering	process	with	extensive	tables	in	the	appendices,	will	facilitate	transferability.
3. One	member	of	 the	research	 team	[ZN]	was	not	 involved	 in	research	design	or	collection	and	was	able	 to	provide	an	 ‘external	audit’19	 to	 the	research	process	and	 findings.	This	 researcher	was	able	 to	critique	data	collected	 towards	enhancing	evidence-based
discussions	and	conclusions	and	therefore	enhancing	dependability	of	the	study	findings.
4. The	study	design,	data	collection	and	analysis	was	undertaken	by	multiple	investigators.	This	facilitated	reflexive	dialogue19	to	develop	complementary	and	divergent	understandings	of	the	study	situation	and	allow	for	confirmability	of	study	findings.
3	Results
3.1	Workshop	findings
3.1.1	Workshop	1:	the	low	acuity	patient	conditions
Fig.	3	shows	how	the	group	discussions	resulted	in	filtering	of	the	total	305,629	NHS	111	calls	firstly	by	the	patient	presenting	complaint	(SD	code);	secondly	by	the	level	of	severity	awarded	to	this	complaint	(SD/SG	combination),	and	lastly	by	the
recommended	timeframe	the	patient	should	seek	care	(DX	code).
The	workgroup	unanimously	agreed	that	any	patient	caller	whose	answers	to	the	NHS	Pathways	questioning	generated	a	disposition	that	required	them	to	be	seen	urgently,	that	is	in	less	than	24	h	by	a	healthcare	professional,	was	not	a	low	acuity
case	appropriate	for	referral	to	community	pharmacy	(highlighted	in	S3	Appendix).
The	SG/SD	combinations	at	DX	PC	contact	24	(Contact	a	primary	care	provider	within	24	h)	or	less	urgent	were	entered	into	the	offline	NHS	111	system	to	extrapolate	the	volume	of	NHS	111	patient	calls	that	could	have	been	redirected	to
community	pharmacy	during	the	6	month	period.	Table	2	shows	the	top	ten	low	acuity	conditions	by	call	volume	(S5	Appendix	includes	the	full	list	of	74).	These	74	low	acuity	conditions	represented	35,974	patient	calls	that	could	have	been	referred	to
community	pharmacy	over	the	6	month	period	in	the	North	East	(NE)	of	England.
Table	2	The	volume	of	NHS	111	patient	calls	attributable	to	the	top	ten	identified	low	acuity	conditions.	(SG:	Symptom	Group,	SD:	Symptom	Descriptor,	PC:	primary	care,	NE:	North	East).
alt-text:	Table	2
SG SD Approx.	no.	of	NHS	111	patient	calls	(Feb–Aug	2016	in	NE	England)	(%)
Repeat	Prescription PC	repeat	prescription,	urgent 6812	(2.2)
Earache PC	full	primary	care	assessment	and	prescribing	capability 2874	(0.9)
Cough PC	full	primary	care	assessment	and	prescribing	capability 2582	(0.8)
Skin	rash PC	full	primary	care	assessment	and	prescribing	capability 2554	(0.8)
Diarrhoea PC	full	primary	care	assessment	and	prescribing	capability 2152	(0.7)
Sore	throat PC	full	primary	care	assessment	and	prescribing	capability 4978	(1.6)
Repeat	Prescription PC	repeat	prescription,	routine 1876	(0.6)
Blisters PC	full	primary	care	assessment	and	prescribing	capability 1572	(0.5)
Headache PC	full	primary	care	assessment	and	prescribing	capability 1496	(0.5)
Lower	back	pain PC	full	primary	care	assessment	and	prescribing	capability 1464	(0.5)
Total 28,360	(9.3)
3.1.2	Results	from	workshop	2:	the	clinically	validated	low	acuity	conditions
Participants	were	presented	with	74	 low	acuity	 conditions	 from	workshop	1,	 of	which	only	11	 reached	 consensus	 as	 appropriate	 to	be	managed	within	 community	pharmacy	 in	 the	 first	 silent	 round	of	 the	NGP.	After	 the	 two	parallel	 group
discussions,	where	the	NHS	Pathways	algorithm	was	reviewed	and	clarity	gained	on	terminology	and	the	extent	of	triage,	eight	SG/SD/DX	combinations	achieved	consensus	amongst	the	clinical	participants	as	not	being	low	acuity	conditions	appropriate	for
management	in	the	community	pharmacy.	This	was	due	to	the	inability	to	satisfy	either	of	the	two	screening	questions	(i.e.	the	clinical	assessment	is	outside	the	competency	of	a	community	pharmacist	and	the	medicinal	product	and/or	healthcare	advice	is
not	available	at	the	pharmacy)	(Table	3).
Table	3	The	volume	of	NHS	111	patient	calls	attributable	to	those	conditions	identified	as	clinically	inappropriate	to	direct	to	community	pharmacy.	(SD:	Symptom	Descriptor,	SG:	Symptom	Group,	PC:	primary	care,
NE:	North	East).
alt-text:	Table	3
SG	Descriptor SD	Descriptor Approx.	no.	of	NHS	111	patient	calls	(Feb–Aug	2016	in	NE	England)
Abdominal	pain PC	full	primary	care	assessment	and	prescribing	capability 286
Fig.	3	The	volume	of	NHS	111	patient	calls	that	were	represented	during	the	process	of	identifying	low	acuity	conditions	within	NHS	Pathways.
alt-text:	Fig.	3
Eye,	painful PC	extended	ophthalmic	assessment	and	management	capability,	minor	condition 0
Eye,	painful PC	assessment	and	management	capability,	minor	condition 0
Eye,	visual	loss	or	disturbance PC	extended	ophthalmic	assessment	and	management	capability,	minor	condition 0
Eye,	visual	loss	or	disturbance PC	assessment	and	management	capability,	minor	condition 0
Head,	facial	or	neck	injury,	blunt PC	full	primary	care	assessment	and	prescribing	capability 414
Mental	health	problem PC	anxiety/panic 0
Pain	and/or	frequency	passing	urine PC	assessment	and	management	capability,	minor	condition 0
Total 700
The	final	agreed	64	low	acuity	conditions	(full	list	in	S5	Appendix)	were	entered	into	the	offline	NHS	111	system	and	equated	to	35,274	patient	calls	(approximately	11.5%	of	the	total	calls	made	to	NHS	111	during	Feb–Aug	2016)	that	could	have
been	referred	to	community	pharmacy	on	an	annual	basis	in	the	North	East	alone.
During	the	nominal	group	discussions	participants	evaluated	the	categorisation	of	low	acuity	conditions	but	further	conversations	yielded	three	key	failure	mode	themes	that	underpinned	all	decisions.	Namely	these	included	patient	experience,
patient	safety	and	added	value.	Strategies	to	manage	and	mitigate	for	the	risk	of	detrimental	impact	to	the	patient	experience	and	safety	and	ensure	added	value	were	also	discussed	and	could	represent	propositions	in	the	design	of	a	community	pharmacy
referral	service.	These	themes	are	explored	further	during	the	discussion.
4	Discussion
Minor	conditions	have	been	recognised	as	those	which	often	require	no	medical	intervention.4	This	study	has	identified	a	definitive	list	of	low	acuity	conditions	that	do	not	warrant	an	appointment	or	consultation	with	a	GP.	The
local	community	pharmacy	can	offer	patients	easy	access	to	a	healthcare	professional	skilled	 in	advising	on	self-limited	conditions	and	recommending	products	 to	 improve	health	and	facilitate	symptomatic	relief.20	Porteous	et	al.
reported	important	factors	that	have	influenced	patients	take	up	of	minor	ailment	services	from	community	pharmacy	such	as	the	provision	of	information	to	help	patients	better	understand	and	manage	their	symptoms;	staff	that	are
well-trained	and	easily	accessible;	the	local	setting	and	availability	of	parking.	The	authors	claim	that	in	meeting	these	desired	elements,	a	shift	in	workload	could	be	achieved	away	from	high-cost	UEC	settings.21,22	The	low	acuity
conditions	determined	in	this	study	have	demonstrated	that	a	clinical	debate	is	warranted	for	some	of	those	conditions	that	have	been	posited	as	low	acuity	or	minor	ailments	in	previous	research.	Namely	cold/’flu	symptoms,3,7,23
cough,3,7,20,23–25	earache,5,23,24	eye	problems,3,7,20,26	have	all	been	classified	as	minor	ailments	in	published	work	with	little	clinical	rationalisation.
Three	low	acuity	conditions	specifically:	cold	and	‘flu;	cough,	and	earache,	provoked	an	extended	debate	amongst	stakeholders	in	this	study.	This	was	due	to	the	skillset	required	for	a	community	pharmacist	to	undertake	a
chest	examination	in	the	assessment	of	a	cough	that	may	also	be	present	with	cold	and	‘flu	symptoms,	and	the	lack	of	prescribing	capability	of	a	community	pharmacist	to	prescribe	antibiotics	in	the	case	of	an	ear	infection	causing	an
earache.	 The	 final	 comments	 of	 the	 group	were	 to	 include	 these	 combinations	 as	 low	 acuity	 conditions	 appropriate	 for	 referral	 to	 community	 pharmacy	 due	 to	 the	 anticipated	 low	 numbers	 of	 patients	 requiring	 either	 a	 chest
examination	(in	patients	suffering	from	cold	and	‘flu,	or	coughs)	or	antibiotics	(in	those	patients	suffering	from	earache).	The	group	recommended	that	there	should	be	a	robust	mechanism	for	appropriate	escalation	where	a	patient
may	require	hands	on	physical	examination	and/or	prescribing	of	a	prescription	only	medicine.	The	group	emphasised	that	numbers	should	be	monitored	of	those	patients	who,	after	being	referred	to	community	pharmacy,	re-enter	the
system	via	the	escalation	procedure,	which	may	highlight	inefficiency,	cost-ineffectiveness	and	a	detrimental	impact	on	patient	care	and	experience.
Previous	work	to	determine	the	burden	of	patients	that	could	be	managed	within	community	pharmacy	rather	than	GP	and	A&E	involved	retrospective	review	of	patient	cases.7,27	However,	the	limitation	of	those	findings	is	that
those	patients	would	all	need	to	present	at	a	point	of	care,	i.e.	GP	and	A&E	by	default,	to	be	assessed	before	it	is	determined	that	they	meet	that	criteria	to	be	managed	within	community	pharmacy.	By	this	point	patients	are	already	at
a	healthcare	setting,	albeit	a	potentially	more	overburdened	and	more	expensive	one,	where	they	are	able	to	receive	care.	The	study	presented	here	takes	advantage	of	a	single	entry	point	of	the	medical	helpline	NHS	111	for	patients,
maps	out	the	algorithms	and	classification	system	of	the	underlying	Pathways	decision	software,	in	order	to	provide	a	proactive	referral	to	the	‘right	place,	first	time’	which	may	be	the	community	pharmacy.	This	study	estimated	that
11.5%	of	NHS	111	calls	in	the	North	East	region	of	England	during	Feb–Aug	2016	could	have	been	redirected	to	community	pharmacy.	This	corresponds	well	with	previous	studies	which	showed	that	13.2%	of	GP	and	5–8%	of	ED
consultations	could	be	directed	for	management	within	a	community	pharmacy.7,27	If	this	proportion	of	patients	were	to	have	been	redirected	to	community	pharmacy	nationally,	779,314	callers	could	have	been	shifted	away	from	UEC
over	this	6	month	period.	Recent	reports	record	that	there	are	approximately	11,688	community	pharmacies	in	England,28	of	which	approximately	900	are	contracted	to	be	open	and	accessible	to	the	public	100	h	a	week.29	If	these
779,314	 patients	were	 referred	 to	 pharmacy	 out	 of	 normal	working	 hours,	 this	would	 represent	 an	 additional	 5	 patents	 per	 day	 per	 100	 h	 pharmacy	 during	Feb–Aug	 2016.	 This	 representation	 is	 based	 on	 assumptions	 of	 even
distribution	of	patient	calls	during	the	time	period	and	of	patients	accessing	community	pharmacy	services	across	geographical	locations.	The	true	impact	of	the	effect	on	workload	would	need	to	be	empirically	investigated	once	such	a
service	is	implemented.
In	the	event	such	a	community	pharmacy	referral	service	would	be	implemented	pharmacists	will	be	undertaking	a	consultation	with	the	referred	patient	in	order	to	determine	the	self-care	and/or	symptomatic	relief	that	can	be
provided.	A	recently	commissioned	service	that	involves	NHS	111	directing	patient	callers	for	repeat	medicines	to	community	pharmacy	includes	a	consultation	fee	of	£10	within	the	remuneration	strategy.30	Recent	reports	estimate	GP
consultations	in	normal	hours	and	out	of	hours	at	£36	and	£96	respectively	(in	the	North	East	taking	into	account	the	block	contract	arrangements).31	However,	to	understand	the	likely	reduced	cost	a	community	pharmacy	referral
service	offers	the	NHS,	a	formal	evaluation	is	required.	Watson	et	al.	also	reported	in	a	recent	study	that	mean	costs	from	an	NHS	perspective	were	significantly	lower	if	patients	were	treated	through	community	pharmacies	for	minor
ailments	when	compared	to	general	practice	and	A&E.3	Another	recent	study	reviewing	retrospective	GP	general	practice	and	ED	data	for	minor	ailment	type	consultations	found	that	approximately	18	million	general	practice	and
650,000	ED	consultations	could	be	redirected	to	community	pharmacy	nationally,	which	they	equated	to	£1.1	billion	in	resources.7	Research	to	date	has	been	unable	to	accurately	measure	the	shift	in	workload	from	UEC	to	community
pharmacy	and	therefore	determine	any	direct	causal	economic	effect.	However	patient	entry	via	NHS	111,	as	suggested	 through	this	study,	offers	 the	capability	 to	record	and	monitor	 the	patient	 journey	as	 they	access	care	and
therefore	potentially	undertake	a	cost-effectiveness	analysis.
The	nominal	group	discussions	accommodated	the	participatory	redesign	of	the	current	NHS	111	system	and	healthcare	delivery.	The	insider	knowledge	of	the	workings	of	NHS	111	and	management	of	low	acuity	conditions
has	proved	invaluable	in	identifying	potential	risks	in	service	redesign	and	finding	solutions	to	mitigate	against	them.	All	group	members	adopted	the	approach	that	any	low	acuity	condition	to	be	directed	to	community	pharmacy
would	have	to	be	one	that	had	a	high	likelihood	of	being	managed	successfully	and	resolved	within	community	pharmacy	(high	case	completion).	The	service	would	then	be	‘adding	value’	since	the	need	for	escalation	and	potential	re-
entry	 into	 NHS	 111	 would	 be	 minimal,	 avoiding	 duplication	 and	 increasing	 costs	 of	 healthcare	 provision.	 This	 aligns	 to	 a	 recent	 systematic	 review	 assessing	 the	 success	 of	 pharmacy	 based	 minor	 ailment	 services	 based	 on
reconsultation	and	symptom-resolution	rates.32	Also	the	patient	experience	would	be	maintained	and	meeting	the	NHS	111	aspiration	of	‘right	advice	in	the	right	place,	first	time’.9	In	existing	studies	on	minor	ailments,	the	patients
have,	 in	the	most	part,	self-presented	at	 the	community	pharmacy	rather	than	been	directed.3,33	Watson	et	al.	demonstrate	 that	 these	patients	had	similar	health	outcomes	to	 those	 in	general	practice	and	ED.3	However,	with	 the
implementation	of	a	community	pharmacy	referral	service	NHS	111	would	be	responsible	and	accountable	for	patients	seeking	care	from	community	pharmacy	as	a	result	of	the	their	referral.	Therefore	the	issue	of	patient	safety	was
recognised	to	require	careful	management	and	governance.	The	group	provided	some	strategies	that	could	be	built	into	the	service	specification	to	address	some	of	the	concerns.	Specifically	assurances	around	the	competency	of	the
healthcare	staff,	quality	of	the	healthcare	provision	and	processes	for	escalation	could	be	guaranteed	by	ensuring	the	service	was	delivered	by	the	community	pharmacist	themselves	rather	than	another	member	of	the	healthcare	team;
utilisation	of	standardised	condition	management	and	differential	diagnosis	tools	such	as	the	Clinical	Knowledge	Summaries	(CKS)	as	issued	by	the	National	Institute	for	Clinical	Excellence	(NICE).34	There	is	recent	research	that	also
recommends	 that	pharmacy-specific	quality	standards	are	required	 to	promote	safe	and	effective	management	of	minor	conditions,19,26	 so	accepted	resources	 to	aid	delivery	of	care	would	be	reasonable	 to	endorse.	The	CKS	also
indicate	‘red	flags’	 that	could	be	used	 to	 trigger	 the	escalation	process,	where	 the	community	pharmacist	 refers	back	 into	NHS	111	 for	 the	patient	 to	 receive	more	appropriate	care.	 It	was	clear	 that	 the	group	supported	robust
governance	 and	monitoring	process	 alongside	 any	 service	 that	would	be	 implemented	with	 the	 changes	 to	 the	NHS	111	 system.	 It	was	not	 deemed	acceptable	 for	 the	 identified	 risks	 on	patient	 experience	 and	 safety	 to	 remain
‘unknown’.	The	service	would	need	project	management	oversight	and	case	completion	and	onward	escalation	rates	would	need	to	be	monitored	over	time.	This	information	should	then	be	fed-back	into	the	evolving	service	design	and
development	to	ensure	efficiency	and	effectiveness	and	mitigate	against	any	detrimental	effects	 to	 the	patient	 journey	and	their	safety.	The	three	specific	Symptom	Groups:	cold	or	 ‘flu;	cough,	and	earache,	which	 triggered	much
debate,	were	used	as	examples	to	demonstrate	that	monitoring	rates	of	onward	escalation	and	case	completion	would	be	instrumental	to	validate	the	continued	redirection	of	these	conditions	to	pharmacy.	The	group	also	determined
that	 an	 ‘exit	 strategy’	 be	 framed	 and	 built	 into	 the	 service	 proposition.	 This	 would	 indicate	 the	 key	 threshold	 at	 which	 the	 service	 would	 no	 longer	 become	 viable	 based	 on	 the	 measured	 key	 performance	 indicators.	 These
recommendations	resonate	well	with	the	Economic	(e.g.	cost	savings	from	redirection	of	patients),	Clinical	(e.g.	reconsultation	and	symptom-resolution-rates)	and	Humanistic	(e.g.	patient	satisfaction)	Outcomes	(ECHO)	model	which
consider	the	value	of	a	pharmaceutical	product	or	service	based	on	the	respective	variables.35
Future	work	could	focus	on	a	before	and	after	study	on	the	delivery	of	the	new	NHS	111	pathway	to	community	pharmacy,	evaluating	for	ECHOs	and	undertaking	a	process	evaluation,	as	recommended	by	the	Medical	Research
Council	for	evaluating	complex	interventions,36	to	further	understand	how	the	service	context,	implementation	and	delivery	impact	upon	service	success.
4.1	Limitations
This	study	has	been	undertaken	in	one	region	of	England	involving	data	and	stakeholders	from	this	area	alone.	However,	the	principle	of	this	study	to	estimate	NHS	111	call	volume	attributable	to	low	acuity	conditions	is
applicable	elsewhere,	and	the	basis	for	a	community	pharmacy	referral	service	is	founded	on	the	knowledge	of	skills	of	the	participants	are	representative	of	their	stakeholder	groups.	Also	the	assessment	of	a	community	pharmacists'
ability	to	manage	these	clinical	conditions	was	based	on	the	current	standard	of	basic	competencies.	With	the	continuous	clinical	evolution	of	the	pharmacist,	e.g.	with	prescribing	capabilities,	this	basic	skillset	may	change	with	time
and	potentially	enable	a	more	extensive	list	of	conditions	to	be	safely	managed	within	the	community	pharmacy.	Finally	the	retrospective	quantitative	data	provided	by	NHS	111	was	based	on	6	months	of	data	that	did	not	include	the
winter	months	where	calls	to	NHS	111	are	significantly	increased.1	Consequently	the	findings	here	may	underestimate	the	annual	burden	that	could	be	directed	to	community	pharmacy.
5	Conclusion
The	participatory	design	approach	towards	developing	an	NHS	111	referral	to	community	pharmacy	for	low	acuity	conditions	has	provided	a	framework	for	transparent	and	reproducible	consensus	development	activities.	The
nominal	 group	discussions	 hold	 a	 richness	 of	 expertise	 and	 insider	 knowledge	 of	 the	 system	 to	 facilitate	 the	 identification	 of	 prospective	 failures	 and	 strategise	working	 solutions	 to	mitigate	 their	 risk	 and	 impact	 on	healthcare
provision.	The	agreed	low	acuity	conditions	resulting	from	this	process	that	could	be	managed	by	community	pharmacy	approximate	to	35,000	patient	calls	per	year	just	in	the	North	East	of	England.	This	potentially	represents	the
improved	capacity	for	urgent	and	emergency	care	to	manage	with	conditions	and	presentations	of	higher	acuity.	This	shift	in	management	of	workload	also	signifies	a	prospective	saving	to	the	NHS.	The	study	activities	were	based	on
the	current	competencies	of	community	pharmacists	in	the	context	of	that	care	setting.	If	significant	changes	were	to	occur,	e.g.	more	widespread	availability	of	pharmacists	with	independent	prescribing	capabilities,	or	review	of	the
current	mechanism	of	commissioning	and	supporting	community	pharmacy	contractual	services,	then	this	definitive	list	would	need	to	be	revised	and	updated.
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S1	Appendix.	The	stakeholders	identified	with	technical	and	clinical	expertise	of	care	provision	via	NHS	111
Stakeholders Knowledge	and	experience
Community	pharmacists	(Clinical) Experience	of	frontline	community	pharmacy	work	and	operation,	and	of	managing	and	referring	self-presenting	patients	with	low	acuity	conditions.
Knowledge	of	the	types	of	low	acuity	conditions	patients	self-present	at	community	pharmacy	on	a	daily	basis;	awareness	of	the	baseline	competence	of	a	community
pharmacist	and	when	patients	should	be	referred	to	another	healthcare	professional.
NHS	111	Clinical	advisor	(Clinical) Experience	of	clinical	decision-making;	managing	risk	through	telephone	triage	and	supporting	non-clinical	staff	within	the	call	centre.
Knowledge	of	clinical	assessment	and	clinical	remit	of	healthcare	providers	within	the	NHS	111	urgent	and	emergency	care	system.
NHS	111	pharmacist	(Clinical) Experience	of	providing	specialised	pharmacy	services	currently	integrated	into	NHS	111	for	urgent	and	emergency	care.
Knowledge	of	the	baseline	competence	of	a	community	pharmacist	and	when	patients	should	be	referred	to	another	healthcare	professional.
Out	of	hours'	clinicians	(Clinical) Experience	of	frontline	urgent	and	emergency	healthcare	provision	across	the	spectrum	of	acuity	of	patient	conditions.
Knowledge	of	the	clinical	assessment	of	patients	with	different	levels	of	acuity	and	their	subsequent	healthcare	needs	to	help	identify	what	is	possible	for	a	pharmacist	to
undertake	safely.
NHS	111	team	leaders	(Non-clinical) Experience	of	managing	patient	calls	for	conditions	of	all	levels	of	acuity	and	directing	these	calls	to	appropriate	healthcare	providers	by	using	the	NHS	Pathways
algorithms.
Knowledge	of	the	technical	terminology,	skilled	questioning	and	technical	operation	of	NHS	Pathways.
Regional	NHS	111	Directory	of
Services	lead	(Non-clinical)
Experience	of	managing	the	Directory	of	Services	and	analysing	the	data	returned	through	NHS	Pathways.	Extensive	experience	of	working	within	models	of	integrated
urgent	care	and	with	technical	development	and	adaptation	of	NHS	Pathways.
Knowledge	of	interpreting	DoS	data	and	the	NHS	Pathways	algorithms,	terminology	and	correct	operation.
Regional	NHS	111	clinical	lead
(Clinical)
Experience	of	managing	the	clinical	governance	structures	that	take	into	account	national	guidance	and	local	commissioner	requirements	to	support	safe	and	appropriate
services	provided	via	NHS	111;	reviewing	NHS	111	call	data	(activity,	nature,	etc)	and	responding	to	serious	incidents	that	are	reported.
Knowledge	of	the	urgent	care	landscape	including	local	provider	organisations,	all	urgent	care	services	and	local	practices;	of	the	nature	and	consequences	of	incidents	that
have	posed	risk	to	patient	safety.
NHS	Pathways	authors	(Non-clinical) Experience	of	frontline	healthcare	as	well	as	extensive	knowledge	of	urgent	and	emergency	care.	They	have	comprehensive	experience	of	developing	the	NHS	Pathways
algorithms	and	mechanisms	for	generating	recommendations	of	referrals	and	determining	level	of	urgency	based	on	the	most	recent	clinical	evidence	available.
Knowledge	of	the	operation	and	creation	of	the	NHS	Pathways	algorithms	and	the	technical	terminology	used	within	it.	They	have	a	wider	knowledge	of	the	direction	of
urgent	and	emergency	care	and	the	consequences	of	the	incidents	that	have	been	reported	through	NHS	Pathways	that	could	pose	a	risk	to	patients.
S2	Appendix.	The	NHS	Pathways	five	main	types	of	Symptom	Discriminators	(SD)
Commissioners	of	NHS	111	and	an
out	of	hours'	service	provider
(Clinical)
Experience	of	reviewing	and	evaluating	healthcare	services	for	their	efficiency	and	effectiveness	of	care	provision;	monitoring	performance	and	managing	the	portfolio	of
services	available	to	patients	and	the	public.
Knowledge	of	the	urgent	care	landscape	including	local	provider	organisations,	all	urgent	care	services	and	local	practices
Symptom
Discriminator
Sub-type Explanation
Ambulance Examples	(non-
exhaustive):
Acute	coronary
syndrome
Septicaemia
Compound	fracture
Shock
These	are	diagnosis	or	symptom-specific	and	of	high	clinical	acuity.	They	are	used	by	ambulance	services	to	help	determine	the	skill	set	and	resources	required	when
attending	999	calls.
Emergency
Department
Full	ED	assessment
and	management
capability
This	means	the	capability	to	perform	a	full	clinical	assessment	of	the	symptom,	as	specified	by	the	SG,	at	the	skill	set	of	an	emergency	department,	and	to	provide
appropriate	investigation	and	definitive	management	without	the	need,	in	most	cases,	for	onward	referral.	For	example,	an	MIU	or	WIC	without	suitable	imaging
facilities	should	not	accept	this	SD	when	combined	with,	e.g.,	SG	‘Head,	Facial	or	Neck	Injury,	Blunt’.
ED	management,
significant	burn
This	means	the	capability	to	perform	a	full	clinical	assessment	and	immediate	management	of	deep	(partial	or	full-thickness)	but	not	extensive	(i.e.	less	than	20%)
thermal	and	chemical	burns,	including	burns	to	areas	such	as	head,	neck,	hands/feet	or	joints.	Onward	referral	to	a	specialist	burns	unit	may	be	required	following
assessment	and	immediate	management.
Full	ophthalmic	ED
assessment	and
management
capability
This	means	the	capability	to	perform	assessment	and	definitive	management	of	isolated	eye	problems,	e.g.	welding	flashes,	foreign	body	or	contact	lens	problems,
which	require	slit-lamp	examination	and	ED	ophthalmological	skills.	This	may	be	part	of	a	general	ED,	specialist	eye	hospital	ED	or	a	separate	unit,	e.g.	a	WIC	or	MIU
with	appropriate	equipment	and	expertise.
Primary	Care Full	primary	care
assessment	and
prescribing	capability
This	means	a	practitioner	with	the	capability	to	perform	a	full	clinical	assessment	of
Primary	Care	conditions	within	the	SG.	The	practitioner	should	be	able	to	prescribe	for	and	manage	the	conditions	and	arrange	investigations,	admission	or	referral	for
specialist	opinion	if	required.
Full	mental	health
assessment	and
prescribing	capability
This	means	a	practitioner	with	the	capability	to	perform	a	full	clinical	assessment	of	mental	health	problems	within	the	SG.	The	practitioner	should	be	able	to	prescribe
for	and	manage	conditions	and	arrange	admission	if	required.
Full	dental
assessment	and
prescribing	capability
This	means	the	capability	to	perform	a	full	clinical	assessment	of	dental	conditions	within	the	SG.	The	practitioner	should	be	able	to	prescribe	for	and	manage	dental
conditions	relating	to	the	SG	and	to	arrange	investigations,	admission	or	referral	for	specialist	opinion	if	required.
Full	obstetric
assessment	and
management
capability
This	means	a	Registered	Midwife	or	Medical	Practitioner,	who	can	provide	assessment	and	advice	for	pregnancy-related	problems	within	the	Symptom	Group	and
arrange	investigation	and	admission	if	required.
Assessment	and
management
capability,	minor
condition
This	means	a	healthcare	professional,	e.g.	an	optician	or	pharmacist,	with	the	capability	to	clinically	assess	and	manage	specific	conditions	within	the	SG	that	are
unlikely	to	require	prescription	medication,	further	investigation	or	onward	referral.
Skill	Set	specific Examples	(non-
exhaustive):
Urinary	catheter
management
capability
Management	of
These	indicate	the	Primary	Care	skillset	required	to	manage	specific	conditions	within	the	SG.
S3	Appendix.	An	example	NHS	Pathways	consultation	report	generated	for	a	patient	caller	calling	NHS	111
with	rectal	bleeding.
dressings
Enteral	feeding	tube
management
capability
Central	venous	line
management
capability
Diagnosis/symptom-
specific
Examples	(non-
exhaustive):
Wound,	complex
Subungual
haematoma
Loose/damaged
plaster
Sexually	transmitted
infection
These	enable	EDs	and	Primary	Care	facilities	to	determine	whether	they	are	equipped	to	provide	assessment	and	definitive	management	of	specific	conditions	within
the	SG,	since	it	is	appreciated	that	different	facilities	will	have	different	skill	sets	and	resources.
alt-text:	Image	2
S4	Appendix.	NHS	Pathways	core	dispositions	(DX	codes)	that	indicate	timeframe	and	most	appropriate
healthcare	setting	for	patient	callers	(those	highlighted	in	boldblue	are	those	receiving	consensus	as
appropriate	for	referral	to	community	pharmacy)
alt-text:	Image	3
Disposition	term Notes
Self-management Would	not	be	referred	anywhere
Home	management Would	not	be	referred	anywhere
S5	Appendix.	The	identified	SG(Symptom	Group)/SD(Symptom	Descriptor)	combinations	achieving	consensus
in	workshops	1	and	2	as	appropriate	for	management	within	community	pharmacy	and	the	associated	volume
of	patient	callers	filtered	by	the	PC	(primary	care)	contact	24	disposition	threshold.
Pharmacy
PC	contact	–	Non-urgent	for	recurrent	symptoms PC:	primary	care
PC	contact	own	GP	non-urgent
MUST	contact	own	GP	3	days
PC	contact	24	h
PC	contact	12	h
PC	contact	6	h
PC	contact	2	h
PC	speak	to	24	h
PC	speak	to	12	h
PC	speak	to	6	h
PC	speak	to	2	h
PC	speak	to	1	h
ED	1	h ED:	Emergency	Department
ED	4	h
No	action	taken
Speak	to	midwife
Optician
Emergency	contraception	2	and	12	h
Dental
Repeat	contact
Ambulance	required
GUM	clinic GUM:	Genitourinary	clinic
Service	location	information
H&SI/specific	disposition H&SI:	Health	and	social	information
SG	Descriptor SD	Descriptor NHS	111	call	volume	(per	annum	in	NE
England)
Notes/comments
Workshop	1 Workshop
2
All	DX DX	>	PC	contact
codes 24
Abdominal	pain PC	full	primary	care	assessment	and	prescribing	capability 7104 286 Removed Not	appropriate	for	community
pharmacy
Acne,	spots	and	pimples PC	assessment	and	management	capability,	minor	condition 30 24 ✓
Acne,	spots	and	pimples PC	full	primary	care	assessment	and	prescribing	capability 14 14 ✓
Allergic	reaction PC	assessment	and	management	capability,	minor	condition 50 42 ✓
Allergic	reaction PC	full	primary	care	assessment	and	prescribing	capability 900 144 ✓
Ankle	or	foot	pain	or	swelling PC	full	primary	care	assessment	and	prescribing	capability 3162 912 ✓
Arm,	pain	or	swelling PC	full	primary	care	assessment	and	prescribing	capability 2126 654 ✓
Athlete's	foot PC	assessment	and	management	capability,	minor	condition 2 2 ✓
Athlete's	foot PC	full	primary	care	assessment	and	prescribing	capability 14 10 ✓
Bites	or	stings,	insect	or	spider PC	full	primary	care	assessment	and	prescribing	capability 2302 16 ✓
Bites	or	stings,	insect	or	spider PC	minor	injury 0 0 Removed Zero	NHS	111	calls
Blisters PC	full	primary	care	assessment	and	prescribing	capability 4832 1572 ✓
Cold	or	flu PC	full	primary	care	assessment	and	prescribing	capability 2086 744 ✓
Constipation PC	full	primary	care	assessment	and	prescribing	capability 2178 486 ✓
Cough PC	full	primary	care	assessment	and	prescribing	capability 5384 2582 ✓
Diarrhoea PC	full	primary	care	assessment	and	prescribing	capability 7412 2152 ✓
Ear	discharge	or	ear	wax PC	assessment	and	management	capability,	minor	condition 12 10 ✓
Earache PC	assessment	and	management	capability,	minor	condition 642 12 ✓
Earache PC	full	primary	care	assessment	and	prescribing	capability 6522 2874 ✓
Eye,	painful PC	extended	ophthalmic	assessment	and	management	capability,	minor	condition
(PEARS)
36 0 Removed Not	appropriate	for	community
pharmacy
Eye,	painful PC	assessment	and	management	capability,	minor	condition 22 0 Removed Not	appropriate	for	community
pharmacy
Eye,	red	or	irritable PC	extended	ophthalmic	assessment	and	management	capability,	minor	condition
(PEARS)
252 210 ✓
Eye,	red	or	irritable PC	full	primary	care	assessment	and	prescribing	capability 208 112 ✓
Eye,	sticky	or	watery PC	extended	ophthalmic	assessment	and	management	capability,	minor	condition
(PEARS)
92 86 ✓
Eye,	sticky	or	watery PC	full	primary	care	assessment	and	prescribing	capability 584 72 ✓
Eye,	visual	loss	or	disturbance PC	extended	ophthalmic	assessment	and	management	capability,	minor	condition
(PEARS)
30 0 Removed Not	appropriate	for	community
pharmacy
Eye,	visual	loss	or	disturbance PC	assessment	and	management	capability,	minor	condition 106 0 Removed Not	appropriate	for	community
pharmacy
Eyelid	problem PC	extended	ophthalmic	assessment	and	management	capability,	minor	condition
(PEARS)
54 50 ✓
Failed	contraception PC	failed	contraception 250 2 ✓
Failed	contraception PC	full	primary	care	assessment	and	prescribing	capability 22 20 ✓
Hair	loss PC	assessment	and	management	capability,	minor	condition 6 6 ✓
Hair	loss PC	full	primary	care	assessment	and	prescribing	capability 22 18 ✓
Head,	facial	or	neck	injury,	blunt PC	full	primary	care	assessment	and	prescribing	capability 2294 414 Removed Not	appropriate	for	community
pharmacy
Headache PC	anxiety/panic 78 72 ✓
Headache PC	depressed	mood 130 122 ✓
Headache PC	full	primary	care	assessment	and	prescribing	capability 4896 1496 ✓
Hearing	problems	or	blocked	ear PC	assessment	and	management	capability,	minor	condition 38 4 ✓
Hip,	thigh	or	buttock	pain	or
swelling
PC	full	primary	care	assessment	and	prescribing	capability 1348 256 ✓
Itch PC	assessment	and	management	capability,	minor	condition 104 90 ✓
Knee	or	lower	leg	pain	or	swelling PC	full	primary	care	assessment	and	prescribing	capability 4948 704 ✓
Lower	back	pain PC	full	primary	care	assessment	and	prescribing	capability 7660 1464 ✓
Lower	limb	pain	or	swelling PC	full	primary	care	assessment	and	prescribing	capability 310 174 ✓
Mental	health	problem PC	anxiety/panic 0 0 Removed Not	appropriate	for	community
pharmacy
Mouth	ulcers PC	assessment	and	management	capability,	minor	condition 100 90 ✓
Mouth	ulcers PC	full	primary	care	assessment	and	prescribing	capability 1094 46 ✓
Mouth	ulcers PC	full	dental	assessment	and	prescribing	capability 8 0 Removed Zero	NHS	111	calls
Nasal	congestion PC	assessment	and	management	capability,	minor	condition 60 50 ✓
Pain	and/or	frequency	passing
urine
PC	assessment	and	management	capability,	minor	condition 252 0 Removed Not	appropriate	for	community
pharmacy
Rectal	pain,	swelling,	lump	or	itch PC	assessment	and	management	capability,	minor	condition 184 174 ✓
Rectal	pain,	swelling,	lump	or	itch PC	full	primary	care	assessment	and	prescribing	capability 1036 392 ✓
Repeat	Prescription PC	repeat	prescription 872 850 ✓
Repeat	Prescription PC	repeat	prescription,	routine 1956 1876 ✓
Repeat	Prescription PC	repeat	prescription,	urgent 7118 6812 ✓
Scabies PC	assessment	and	management	capability,	minor	condition 8 8 ✓
Shoulder	pain PC	full	primary	care	assessment	and	prescribing	capability 1114 604 ✓
Skin	rash PC	full	primary	care	assessment	and	prescribing	capability 11,672 2554 ✓
Uncited	reference
15.
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